The CPV West Virginia CCGT Plant is 2,060MW gas fired power project. It is planned in West Virginia, the US. According to GlobalData, who tracks and profiles over 170,000 power plants worldwide, the project is currently at the permitting stage. It will be developed in a single phase. The project construction is likely to commence in 2025 and is expected to enter into commercial operation in 2026. Buy the profile here.
Description
The project is being developed and currently owned by Competitive Power Ventures. The company has a stake of 100%.
It is a Combined Cycle Gas Turbine (CCGT) power plant.
Development status
The project construction is expected to commence from 2025. Subsequent to that it will enter into commercial operation by 2026.
Contractors involved
GE Power will be the turbine supplier for the Gas fired project. The company is expected to supply HA.03 model gas turbines for the project.
For more details on CPV West Virginia CCGT Plant, buy the profile here.
About Competitive Power Ventures
Competitive Power Ventures Inc (CPV) is a power generation development and asset management company. The company develops combined-cycle natural gas and wind power projects to produce clean energy. Its project development activities include project conceptualization, market analysis, community relations, government affairs, permissions, financing, construction, and commercial operation. It also offers electric generation asset management services. CPV’s asset management division manages fossil and renewable generating facilities in different states in the US. It has presence in Silver Spring, Maryland; Braintree, Massachusetts; and San Francisco, California. CPV is headquartered in Silver Spring, Maryland, the US.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.